• top_image

MIOCA IN THE NEWS

Please see our news in the archive to the right.

Drug Quality and Security Act

November 24, 2013

Congress has approved the Drug Quality and Security Act and it’s now on its way to the White House for signature.  The Drug Quality Security Act means safer compounded drugs and greatly diminishes the risk of counterfeit drugs making it into our homes.  It establishes a system to track and regulate compounded drugs from manufacturing to distribution.  The Alliance has been working on this issue in a coalition led by Pew Charitable Trusts. More information here.

Doxil Shortage, Again

November 18, 2013

The main supplier of Doxil has decided to close their plant and discontinue production of the drug. Johnson & Johnson, the distributor, said it therefore is likely the Doxil shortage will continue through the end of 2014.  Due to FDA approval process, it is doubtful that Johnson & Johnson will have a new supplier before the end of 2014.  More information for patients and families can be found here.

Information to help determine new insurance coverage

November 6, 2013

Enrollment for the Health care Marketplaces opened on October 1st (with coverage starting January 2014).  The options for insurance for cancer patients can be overwhelming, so the Alliance created a checklist to help when researching coverage in the marketplaces. The Checklist was created with cancer patients' needs in mind to ensure all bases are covered when comparing health insurance plans.

Spartan’s alum responds to Go Blue by raising funds to fight ovarian cancer

September 19, 2013

MSU Alumni Association Executive Director, Scott Westerman, issued a challenge to the Spartan faithful after “Go Blue” appeared over their stadium last Saturday. Saying the money spent on that flight could have been put to better use, he challenged Spartan's nationwide to exceed that amount in donations to the MIOCA .  Scott's wife, Colleen, is treated at University of Michigan Hospital for ovarian cancer, and he will challenge his counterpart at the UMAA to do the same, "Let's show the world what Leaders, Lifesavers and World Changers do".

The response has been tremendous. We are greatly appreciative of Scott & Colleen and everyone that has donated! We will use these funds to further our mission and help save women’s lives. Thank you from the MIOCA Board, volunteers, and all ovarian cancer survivors! , 

Some of the press: MLiveCBSSportsDetroit Free PressMLiveESPNFox NewsExaminerDetroit NewsWLNS TVUSA TODAYHuffington Post and more!

Promising New Research Results For Early Detection Screening

August 29, 2013

MD Anderson Cancer Center published new findings indicating that evaluating the change in CA125 levels over time shows some promise as a screening method for early ovarian cancer. The 11 year long study followed 4,000 low risk women that underwent yearly blood tests for the CA125 cancer marker. Those that showed a sudden increase were referred to a gynecologist and received an ultrasound. The study suggested that the testing strategy had a specificity of 99.9 percent, the researchers said, meaning that only 0.1 percent of patients without cancer would be falsely identified as having the disease. Read more here.

Research Report from ASCO 2013

June 27, 2013

The Alliance leadership recently attended the American Society of Clinical Oncology (ASCO) annual meeting, an event that annually gathers thousands of cancer researchers from around the world. Many new studies on or related to ovarian cancer were presented at this year’s meeting and were summarized by the Alliance. Read the <link href="http://www.ovariancancer.org/report-from-asco-2013-new-research-on-ovarian-cancer/">summary</link>&amp;nbsp;here as well as some other relevant research presented at the meeting.

Supreme Court Strikes Down BRCA Gene Patents

June 13, 2013

The Supreme Court ruled unanimously on June 13 that private companies do not have the right to patent human genes, including those associated with an increased risk of ovarian and breast cancer - the BRCA1 and BRCA2 mutations. Many cancer advocates applauded the decision, in the hope it will allow for easier, less expensive access to genetic testing, and&amp;nbsp; more research to be done on these genes.Read the <link href="http://www.ovariancancer.org/2013/06/13/press-release-ovarian-cancer-advocates-praise-supreme-court-decision-on-gene-patents/">statement from the Alliance</link>.Read the <link href="http://www.nytimes.com/2013/06/14/us/supreme-court-rules-human-genes-may-not-be-patented.html?_r=0">New York Times story</link>.

The Supreme Court ruled unanimously on June 13 that private companies do not have the right to patent human genes, including those associated with an increased risk of ovarian and breast cancer - the BRCA1 and BRCA2 mutations. Many cancer advocates applauded the decision, in the hope it will allow for easier, less expensive access to genetic testing, and&amp;nbsp; more research to be done on these genes.
Read the <link href="http://www.ovariancancer.org/2013/06/13/press-release-ovarian-cancer-advocates-praise-supreme-court-decision-on-gene-patents/">statement from the Alliance</link>.
Read the <link href="http://www.nytimes.com/2013/06/14/us/supreme-court-rules-human-genes-may-not-be-patented.html?_r=0">New York Times story</link>.

International Study Discovers New Genetic Markers for Cancer

April 11, 2013

A collaboration of more than 130 institutions analyzing data from more than 200,000 people revealed new genetic markers for breast, prostate and ovarian cancer. 

Society of Gynecologic Oncology 2013 Annual Meeting

April 11, 2013

At this year’s SGO Annual Meeting numerous presentations explored issues related to ovarian cancer. The Alliance summarized some of them, with topics including diagnosis, treatment, recurrence, prognosis and more, in a <link href="http://www.ovariancancer.org/2013/04/02/report-from-the-society-of-gynecologic-oncology-2013-annual-meeting/">report here.</link>&amp;nbsp;

The New York Times reports on study finding inadequate care for ovarian cancer

March 13, 2013

The<emphasize>&amp;nbsp;New York Times</emphasize>&amp;nbsp;reported on a study presented at the 2013 meeting of the Society of Gynecologic Oncologists that found most women with ovarian cancer do not receive adequate care or treatment. This study, from the University of California, Irvine, found women are more likely to get optimal care when treated at a medical center that handles a high volume of ovarian cancer cases.

Possible Link Between High Blood Calcium Levels and Ovarian Cancer

January 24, 2013

The Wake Forest Baptist Medical Center reports that high blood calcium levels might predict ovarian cancer. The study found, “women who were later diagnosed with ovarian cancer and women who later died of ovarian cancer had higher levels of calcium in blood than women who did not before their cancer diagnosis.”<link href="http://www.wakehealth.edu/News-Releases/2013/Study_Shows_High_Blood_Calcium_Levels_May_Indicate_Ovarian_Cancer.htm">Read report here.</link>

The Wake Forest Baptist Medical Center reports that high blood calcium levels might predict ovarian cancer. The study found, “women who were later diagnosed with ovarian cancer and women who later died of ovarian cancer had higher levels of calcium in blood than women who did not before their cancer diagnosis.”
<link href="http://www.wakehealth.edu/News-Releases/2013/Study_Shows_High_Blood_Calcium_Levels_May_Indicate_Ovarian_Cancer.htm">Read report here.</link>

Pap Test Might Detect Ovarian Cancer

January 11, 2013

Researchers at Johns Hopkins showed that examining cervical cells can help identify ovarian and uterine cancers. In a recent small study of 46 women, DNA analysis detected 41% of ovarian cancer cases.<link href="http://www.hopkinsmedicine.org/news/media/releases/johns_hopkins_scientists_use_pap_test_fluid_to_detect_ovarian_endometrial_cancers">Read study here.</link>

Researchers at Johns Hopkins showed that examining cervical cells can help identify ovarian and uterine cancers. In a recent small study of 46 women, DNA analysis detected 41% of ovarian cancer cases.
<link href="http://www.hopkinsmedicine.org/news/media/releases/johns_hopkins_scientists_use_pap_test_fluid_to_detect_ovarian_endometrial_cancers">Read study here.</link>